Kevin Rooney
Directeur/Membre du Conseil chez National Foundation for Infectious Diseases
Profil
Kevin M.
Rooney is currently the Treasurer & Director at the National Foundation for Infectious Diseases and the Chief Business Officer at F3 Platform Biologics, Inc. He previously worked as the Senior Director-Marketing & Marketing Director at Bristol Myers Squibb Co. from 1997 to 2003, Independent Director at GenVec, Inc. from 2008 to 2013, Vice President-Sales & Marketing-Oncology Division at MedImmune LLC from 2003 to 2007, and President at Beacon Consulting Group, Inc. He also served as the EVP-Commercial Operations at QOL Medical LLC from 2019 to 2021.
Mr. Rooney received his undergraduate degree from the University of Virginia and his graduate degree from Northwestern University.
Postes actifs de Kevin Rooney
| Sociétés | Poste | Début |
|---|---|---|
National Foundation for Infectious Diseases
 National Foundation for Infectious Diseases Miscellaneous Commercial ServicesCommercial Services National Foundation for Infectious Diseases engages in providing information and resources about vaccines recommended for adults, adolescents and children, including links to updated Center for Disease Control and Prevention (CDC) Immunization Schedules and a Fact Sheet about how vaccines work. The company is headquartered in Bethesda, MD. | Directeur/Membre du Conseil | - |
F3 Platform Biologics, Inc.
 F3 Platform Biologics, Inc. BiotechnologyHealth Technology F3 Platform Biologics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of novel and practical biotechnology for human use. It handles research, clinical development, and commercialization of new indications surrounding amifostine, a compound that has been previously approved by FDA for indications involving the prevention and treatment of side effects related to cancer treatment and radiation therapy. The company was founded on June 5, 2018 and is headquartered in Atlanta, GA. | Corporate Officer/Principal | 01/01/2022 |
Anciens postes connus de Kevin Rooney
| Sociétés | Poste | Fin |
|---|---|---|
QOL Medical LLC
 QOL Medical LLC Pharmaceuticals: MajorHealth Technology QOL Medical LLC distributes bio pharmaceutical products. It offers treatment for gastroenterology, pharmaceuticals, biotechnology, orphan and rare diseases. The company was founded in 2003 and is headquartered in Vero Beach, FL. | Directeur des opérations | 02/01/2021 |
| GENVEC INC | Directeur/Membre du Conseil | 04/09/2013 |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Sales & Marketing | 01/01/2007 |
| BRISTOL-MYERS SQUIBB COMPANY | Sales & Marketing | 01/07/2003 |
Beacon Consulting Group, Inc.
 Beacon Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Beacon Consulting Group, Inc. operates as a construction consulting firm. It offers surety consulting, construction management, pre-construction services and estimating, construction claims, funds control and construction loan monitoring, project control and scheduling services, construction defects assessment, and quality assurance and control. The company was founded by Robert Kaplan in 2000 and is headquartered in New York, NY. | President | - |
Formation de Kevin Rooney
| University of Virginia | Undergraduate Degree |
| Northwestern University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Entreprise privées | 6 |
|---|---|
GenVec, Inc.
 GenVec, Inc. Pharmaceuticals: MajorHealth Technology GenVec, Inc. operated as a clinical-stage gene delivery company, which engaged in the development of therapeutics and vaccines. The firm designs, tests, and manufactured adenoviral-based product candidates using its proprietary AdenoVerse platform. Its products included CGF166-Hearing Loss; GV2311-RSV Vaccine; and GV2207-HSV-2 Immunotherapeutic. The company was founded in December 1992 and was headquartered in Rockville, MD. | Health Technology |
Beacon Consulting Group, Inc.
Beacon Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Beacon Consulting Group, Inc. operates as a construction consulting firm. It offers surety consulting, construction management, pre-construction services and estimating, construction claims, funds control and construction loan monitoring, project control and scheduling services, construction defects assessment, and quality assurance and control. The company was founded by Robert Kaplan in 2000 and is headquartered in New York, NY. | Commercial Services |
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
National Foundation for Infectious Diseases
National Foundation for Infectious Diseases Miscellaneous Commercial ServicesCommercial Services National Foundation for Infectious Diseases engages in providing information and resources about vaccines recommended for adults, adolescents and children, including links to updated Center for Disease Control and Prevention (CDC) Immunization Schedules and a Fact Sheet about how vaccines work. The company is headquartered in Bethesda, MD. | Commercial Services |
F3 Platform Biologics, Inc.
F3 Platform Biologics, Inc. BiotechnologyHealth Technology F3 Platform Biologics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of novel and practical biotechnology for human use. It handles research, clinical development, and commercialization of new indications surrounding amifostine, a compound that has been previously approved by FDA for indications involving the prevention and treatment of side effects related to cancer treatment and radiation therapy. The company was founded on June 5, 2018 and is headquartered in Atlanta, GA. | Health Technology |
QOL Medical LLC
QOL Medical LLC Pharmaceuticals: MajorHealth Technology QOL Medical LLC distributes bio pharmaceutical products. It offers treatment for gastroenterology, pharmaceuticals, biotechnology, orphan and rare diseases. The company was founded in 2003 and is headquartered in Vero Beach, FL. | Health Technology |
